Document:

Severance Agreement and General Release

 Exhibit 10.1 
  
 SEVERANCE AGREEMENT AND GENERAL RELEASE 
  
 This Severance Agreement (“Agreement”) is entered into by and between Stephen J. Aselage (“Employee”)
and Cell Therapeutics, Inc. (“Employer” or “CTI”). 
  
 RECITALS 
  
 A. Employee has been continuously employed
by Employer since February 2, 2004 most recently in the capacity of Executive Vice President, Global Commercial Operations. 
  
 B. Employer and Employee have mutually decided to terminate Employee’s employment as of June 30, 2005 (the “Separation Date”). 

 
 C. Employee and Employer wish to enter into an agreement to terminate the
employment relationship and to clarify and resolve any disputes that may exist between them, including any arising out of the employment relationship and its termination, and the continuing obligations of the parties to each other following the end
of the employment relationship. 
  
 AGREEMENTS 
  
 NOW, THEREFORE, in consideration of the foregoing recitals and the mutual
promises contained below, it is agreed as follows: 
  
 1.
TERMINATION OF EMPLOYMENT 
  
 Employee’s employment with
Employer terminated effective June 30, 2005. Employee and Employer agree that the mutual covenants and agreements contained in this Agreement constitute full and valid consideration for the termination of the Employment relationship and the release
obligations. Employer will not oppose unemployment benefits. 
  
 2. SEVERANCE AND BENEFITS 
  
 A.
Employer will pay to Employee a total of $137,500.00 which is the equivalent to six (6) months wages at the employee’s current annual wage. Severance will be paid in twelve (12) bi-monthly payments of $11,458.33. Employee acknowledges and
agrees that all amounts payable are subject to withholding by the Employer for federal (state and local, if applicable) taxes, FICA and any other government mandated withholdings. These payments will be processed in the normal payroll processing
schedule following the expiration of the seven day revocation period of this agreement, as administratively feasible. 
  

 - 1 - 

 B. Employee’s existing health insurance will be discontinued as of June 30, 2005.
Employee and covered dependents have the opportunity to continue group medical, dental and EAP insurance through CTI. pursuant to rights under the federal COBRA statute. 
  
 C. As of the Separation Date, Employee shall be vested in the stock options set forth in Schedule
1.1, which options shall be exercisable for three (3) months from the Separation Date and which shall be automatically forfeited if not exercised within such timeframe. In addition, Employee will continue to vest in the stock options set forth
in Schedule 1.2 in accordance with the vesting schedule set forth in the applicable option agreement(s) until February 28, 2006, which options shall be exercisable for three (3) months from February 28, 2006 and which shall be automatically
forfeited if not exercised within such timeframe. Employee shall forfeit the options which shall not continue to vest as set forth in Schedule 1.3. Options not forfeited as of the Separation Date shall otherwise continue to be subject to the
other terms and conditions of the applicable option agreement, including earlier termination upon the stated expiration date of the option or in accordance with the adjustment or change in control provisions of the plan under which they were
granted. Furthermore, the shares of restricted stock as set forth in Schedule 2.1 hereto will be deemed fully vested as of June 30, 2005 (and applicable taxes shall be paid by Employee with respect thereto); Schedule 2.2 hereto sets
forth restricted stock grants held by the Employee that shall be forfeited as of the Separation Date in accordance with the terms and conditions of the applicable award. 
  
 D. Employee’s vacation accrual will cease as of June 30, 2005. Employee’s accrued and unused
vacation time will be paid out on the employees final pay check. 
  
 3. RELEASE 
  
 Employee releases Employer, its officers,
directors, managers, agents, attorneys, employees, representatives, administrators, and successors, from all claims he has or may have, whether known or unknown, against Employer as of the date he executes this Agreement, including, but not limited
to, claims in any way connected with Employee’s employment with Employer and/or the termination of that employment. Employer releases Employee, his agents, attorneys, representatives, administrators, and successors, as of the date he executes
this Agreement, from all claims it has or may have, whether known or unknown, including, but not limited to, claims in any way connected with Employee’s employment with Employer and/or the termination of that employment. The rights and claims
covered by these releases of claims include, without limitation, all rights or claims arising out of any contracts, expressed or implied (except as set forth in paragraphs 4,5 and 6 below), any tort theory, any theory of wrongful discharge or
negligent or intentional wrongdoing, any claim of retaliation or whistleblower protection, or any Federal, State or other governmental statute, ordinance or regulation, without limitation as to subject matter, including, but not limited to, Title
VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, The Civil Rights Act of 1991, 
  

 - 2 - 

 the Americans With Disabilities Act, the Fair Labor Standards Act, the Family and Medical Leave Act, the Older Workers
Benefit Protection Act, any federal, state or local whistleblower protection statute, ordinance or regulation, the Employment Retirement Income Security Act, the state law against discrimination in the state of Employee’s residence, any state
family leave law in the state of Employee’s resident, any claim for lost benefits or wages (whether present or future), attorneys’ fees and costs, and any other legal limitation on the employment relationship or regulation or statute
pertaining to the employment relationship in any way. It is the intention of both parties to make this release as broad and general as the law permits. 
  
 4. CONFIDENTIALITY 
  
 Except as required by applicable law, Employer and Employee agree to keep all aspects of this Agreement confidential including, but not limited to, the
terms of this Agreement and the negotiations that lead up to this Agreement. Employer and Employee agree they will not disclose this information in any manner, whether in writing or orally, to any person, directly or indirectly, or by or through any
agent, representative, attorney, or any other such person, except that the Employer and Employee may disclose this information necessary in the course of preparing financial documents, income tax returns, dealing with the Internal Revenue Service or
any state taxing authority, or as otherwise required by law, or as to Employer, in the preparation and dissemination of information to its officers, Board of Directors and shareholders or as required for Employer’s reporting purposes.

  
 Employee agrees not to discuss with any current or former
employer, or any third party, any issues relating to Employee’s employment with Employer, including personnel matters. This does not preclude the Employee from discussing with any third parties or prospective employers the nature of the work
which Employee performed at Employer. 
  
 Employee agrees to
maintain and preserve all confidential information and trade secrets of the Employer of which he is aware and specifically reaffirms and agrees to be fully bound by the terms of the Employee Agreement dated February 3, 2004, the confidentiality and
trade secrets provisions of which shall survive this Agreement. Employee agrees that such confidential information includes, but is not limited to, information about sales of any CTI products, the marketing of those products, and potential plans or
strategies for increasing sales of those products. Employee agrees that he will not, unless compelled to do so by subpoena and then only after notice to CTI through written notice to CTI’s in-house General Counsel at least five days prior to
the return date of the subpoena, discuss with, relate to, complain to, or bring to the attention of any governmental agency, whether state, local or federal, or any other person, including media, any of CTI’s confidential information and trade
secrets. 
  
 Employer and Employee agree not to make any
disparaging remarks about the other. 
  
 Employee represents that
he understands that the terms and conditions of this paragraph are an integral part of this Agreement and that Employer can seek appropriate 
  

 - 3 - 

 damages for a breach of such terms, including but not limited to injunctive relief or monetary damages. Employer is also
entitled to all relief set forth in the preceding sentence in the event of Employee’s breach of any term and condition of this Agreement. Employee acknowledges his duties, responsibilities and obligations subsequent to the termination of
employment as outlined in documents earlier executed by his with Employer. 
  
 5. DUTY TO COOPERATE 
  
 Employee
agrees to cooperate with Employer in all matters and/or proceedings arising out of the Employer’s business about which Employee has knowledge or information. Such proceedings may include, but are not limited to, internal investigations,
administrative investigations or proceedings, administrative matters and lawsuits (including pretrial discovery). Employee agrees to make himself available for interviews, meetings, depositions, hearings and/or trials without the need for subpoena
or assurances by Employer, providing any and all documents in his possession that relate to the proceedings, and providing assistance in locating any and all relevant notes and/or documents is necessary. 
  
 Employee agrees not to provide information to, be interviewed by, communicate
with or give statements to third parties relating to any matter about which Employee has knowledge or information and which relates in any way to Employer and/or Employer’s business. To the extent that Employee is asked to provide any such
information formally and informally, Employee shall immediately (within one (1) day) notify CTI’s in-house General Counsel by fax or email. Employee agrees that he will not informally or formally provide statements, interviews or any other
information relating to Employer’s business and/or other former or current employees of Employer without the written consent of Employer. 
  
 In the event that Employee is served with any legal service of process including, but not limited to, notices of deposition, subpoenas and the like,
Employee will immediately (within one (1) day) notify CTI’s in-house General Counsel by fax or email and provide a complete copy of all documents received. Employee will not provide any information including documents voluntarily without the
written consent of Employer. 
  
 Employee represents that he
understands the terms and conditions of this paragraph are an integral part of this Agreement and that Employee can seek appropriate damages for a breach of such terms including, but not limited to, injunctive relief or monetary damages. Employer is
also entitled to all relief set forth in the preceding sentence in the event of Employee’s breach of any term and condition of this Agreement. Employee acknowledges his duties, responsibilities and obligations subsequent to termination of
employment. 
  
 6. COVENANT NOT TO COMPETE 
  
 Employee agrees that for a period of one (1) year following the termination
of his employment, he will not (i) call on or contact collaborators (and related institutions), 
  

 - 4 - 

 consultants, vendors, suppliers or customers of Employer regarding the discovery, development, manufacture or sale of a
third party product or service which competes with or is related to any of the Employer’s products or services, or (ii) actively recruit away any employee of the Employer. 
  
 7. FULL AND FINAL SETTLEMENT 
  
 Employee and Employer represent and agree that they have read this Agreement, understand its terms and the fact that it releases any and all claims each
might have against the other, and have entered into this Agreement without duress or coercion from any source. This agreement supersedes any and all other Employment Agreements entered into between Employee and Employer, except the terms and
conditions of Employee’s Employment Agreement dated February 3, 2004, related to Employer’s confidential information and trade secrets. 
  
 8. SEVERABILITY 
  
 The provisions of this Agreement are severable, and if any part of it is found to be unlawful, the other provisions of this Agreement shall remain fully
valid and enforceable to the maximum extent consistent with applicable law. 
  
 9. ENTIRE AGREEMENT/NOTICE 
  
 This Agreement sets forth the entire understanding between Employee and Employer and supersedes any prior agreements or understandings pertaining to the terms of Employee’s employment with Employer except as set forth in paragraph
number (4) above. 
  
 10. PERIOD FOR ACCEPTANCE 
  
 Employee acknowledges that he has carefully read and fully understands all
the provisions of this Agreement and that he is entering into the Agreement knowingly and voluntarily. Employee has twenty-one (21) days to consider whether to accept this Agreement but may accept this Agreement prior to the expiration of those
twenty-one (21) days. If Employee elects to accept the conditions of this Agreement, Employee will advise Employer by delivering an executed copy of this Agreement to Richard Leigh of Cell Therapeutics, Inc., 501 Elliott Avenue West, Seattle,
Washington 98119, within twenty-one (21) days of receipt of this Agreement. This Agreement was hand delivered to Employee on June 28, 2005. 
  
 11. PERIOD FOR REVOCATION 
  
 Employee may revoke his acceptance of this Agreement at any time prior to the eighth (8th) day following the date of his acceptance of this Agreement
(“Period of Revocation”). Notice of revocation shall be in writing and delivered to and received by Richard Leigh of Cell Therapeutics, Inc., 501 Elliott Avenue West, Seattle, Washington 98119. If not revoked, this Agreement shall be
effective as of the date Employee signs this Agreement as indicated by his signature below (“Effective Date”). 
  

 - 5 - 

 12. GOVERNING LAW 
  
 This Agreement shall be governed by the laws of the State of Washington. If it shall be necessary to enforce the terms of
this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees and costs including but not limited to those incurred prior to any litigation, during litigation and on appeal. Venue for any such action will be King County,
Washington. 
  
 YOU ACKNOWLEDGE THAT YOU HAVE CAREFULLY READ
AND FULLY UNDERSTAND ALL OF THE PROVISIONS OF THIS AGREEMENT; THAT CTI ADVISED YOU IN WRITING (AND THIS PARAGRAPH CONSTITUTES SUCH WRITTEN ADVICE) TO CONSULT AN ATTORNEY REGARDING THIS AGREEMENT; THAT CTI SHALL HAVE NO RESPONSIBILITY TO REIMBURSE
YOU FOR ANY LEGAL FEES INCURRED BY YOU IN CONNECTION WITH THE REVIEW OR NEGOTIATION OF THIS RELEASE; THAT YOUR EXECUTION OF THIS AGREEMENT IS VOLUNTARY AND UNCOERCED. 
  
 IN WITNESS WHEREOF, the parties have executed this Agreement on the dates indicated below. 
  

					
	 EMPLOYEE
	 	 EMPLOYER

		
	 	 	 CELL THERAPEUTICS, INC.

			
	 /s/ Stephen Aselage

	 	 By
	 	 /s/ James Bianco

	 	 	 Title
	 	 President & CEO

	 	 	 	 	 501 Elliott Avenue West

	 	 	 	 	 Seattle, Washington 98119

		
	 Date: June 28, 2005
	 	 Date: June 14, 2005

  

 - 6 -Summary of Non-Employee Director Compensation

 Exhibit 10.1 
  
 Summary of Non-Employee Director Compensation 
  
 Initial Equity Grant. Each newly appointed or elected non-employee director is granted, pursuant to the
Company’s 2001 Stock Incentive Plan or 2004 Stock Incentive Plan, a number of unrestricted shares of common stock of the Company (“Common Stock”) having a valuation equal to approximately $90,000, valued at the per share closing price
of the Common Stock as of the effective date of such director’s appointment or election. 
  
 Annual Equity Grant. At the Board’s first regularly scheduled meeting of each year, each non-employee director is granted shares of Common Stock having a valuation equal to $55,000, valued at the
per share closing price of the Common Stock as of the date of such first Board meeting.  
  
 Retainer and Fees. Each non-employee director receives an annual retainer of $20,000 (plus an additional $10,000 for the Audit Committee
chairman and an additional $5,000 for each other Board committee chairman) paid quarterly and reimbursement of reasonable incidental expenses. Each non-employee director also receives $1,500 for attendance at each Board meeting held “in
person” and $1,000 for attendance at each Board meeting held by conference call. In addition, each non-employee director receives $1,500 for each Board committee meeting attended (plus, in the case of a Board committee chairman, an additional
$1,000 for each committee meeting after the fourth such meeting in any given year). 
  
 Other Benefits. Each non-employee director is eligible to participate, at such director’s cost and election, in the Company’s medical and dental plans. 
  
 Employee Directors. A director who is also an employee of the
Company receives no additional compensation for services as a director.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]